Haemophilus b Conjugate Vaccine Articles
Malaysia views on-line pharma sales
7 August 2000
US bipartisan progress on HMO decision appeals
17 April 2000
New Zealand's Internet pharmacy loophole
26 January 2000
Bill would curb HMO hikes for Rx cover
10 January 2000
Likely defeat for Ohio (USA) Rx drug bill
20 October 1999
US doctor charged over Internet Rxing offenses
13 July 1999
New body to regulate genetic R&D in Canada
17 May 1999
S Carolina Rx info privacy act moves on
27 April 1999
UK Code of Practice: 144 complaints in 1998
31 March 1999
US generics access bill introduced in House
3 March 1999
New UK obesity guidelines highlight role of drugs
25 January 1999
Easy Path For Viagra Approval In Japan?
26 October 1998
FDAMA "Must Be Top Agency Priority:" Henney
2 September 1998
Seniors' Rights To Choice In Medical Care
7 April 1998
PhRMA's Views Of IP, Free Markets And Cloning
18 February 1998
Thalidomide Closer To US Market For Leprosy
10 September 1997
US Generic Makers' Terms For Accepting User Fees
19 May 1997
WHO Calls For Ban On Human Cloning
19 March 1997
Hungarian Cabinet Passes Drug Ad Law
17 February 1997
New Jersey Proposes Tough New Rules For HMOs
17 February 1997
Genentech Files Against Novo Nordisk On Insulin
7 October 1996
Labeling Laws Opposed
15 July 1996
Californians To Vote On Managed Care "Abuses"
24 June 1996
1996 - A Year Of Decision, Says Germany's VFA
24 June 1996
Pharmacoeconomic Claims: FTC Views
5 February 1996
Clinton Signs Spending Bill To Mid-March
5 February 1996
US Legal Group Files Suit On IND Disclosure
15 January 1996
New Challenges Facing EU Pharma Wholesalers
13 November 1995
Medicare Preservation Act: Current Proposals
23 October 1995
US Industry Welcomes China Trade Treaty
6 March 1995
"First Amendment Issues" In Suit Against US FDA
27 February 1995
Israeli MoH Opposes Patent Extension
6 February 1995
US FDA Seeks Views On CME Plan
28 November 1994
US FTC "Unlikely" To Curb PBM Strategies
21 November 1994
New UK Advertising Regs Implement EU Law
31 October 1994
US FDA Plans Financial Disclosure For Researchers
3 October 1994
Democrat Hopes Fade For Health reform This Year
26 September 1994
France Cuts Drug Prices, Bans Promo Campaigns
5 September 1994
US Democrats Unveil Their National health Plan
8 August 1994
DECLINES IN 1st QTR AT ARES-SERONO
13 June 1994
GENENTECH'S hGH APPROVED IN USA
21 March 1994
COMPROMISES IN US HEALTH REFORM PLANS
31 January 1994
EFFECTS OF NAFTA ON PHARMA TRADE
1 November 1993
MAJOR DRUG FIRMS IN US PRICE FIXING LAWSUIT
25 October 1993
INVESTIGATIONS INTO CAREMARK ONGOING
11 October 1993
MANDATORY DRUG PRICE CONTROLS RULED OUT
13 September 1993
CANADA AND INTELLECTUAL PROPERTY
2 August 1993
INDIA: A PATENT REGIME FOR DRUG SECURITY
21 June 1993
BOOTS' FLOSEQUINAN IN FURTHER TROUBLE?
14 June 1993
CANADIAN R&D BOOST FROM INDUSTRY
31 May 1993
MANAGED CARE CENTRAL TO HEALTH CARE REFORM
24 May 1993
US DRUGMAKERS GOING IN FOR MORE LOBBYING
17 May 1993
BRAZIL INDUSTRY TO CHALLENGE GOVT?
3 May 1993
MERCK PRICE CONTROL OFFER TO CLINTON
26 April 1993
PASTEUR MERIEUX VACCINE DEVELOPMENTS
19 April 1993
INFLUENZA B IMMUNIZATION
4 January 1993
UK INDUSTRY PROTEST OVER NHS LIST PLANS
4 January 1993
EC COURT OVERTURNS UK DRUG PATENT RULING
9 November 1992
BRAZIL'S PRESIDENT OKs PATENT BILL
29 June 1992
INDUSTRY VIEWS US FDA CME GUIDE
16 March 1992
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
